BMT CTN Protocol 0201 -- A Phase III Randomized Multicenter Trial Comparing G-CSF Mobilized Peripheral Blood Stem Cell with Marrow Transplantation from HLA Compatible Unrelated Donors

Below are protocol-related doucments, which may be periodically updated.

• Protocol synopsis, version 8.0 dated September 15, 2006
• Protocol, version 8.0 dated September 15, 2006
• Protocol amendment (summary of changes from version 7.0 to 8.0)
• Informed consents, version 8.0 dated September 15, 2006
• Health Quality of Life (HQL)
• Patient Questionnaire
• Participating centers
• Educational Materials
• Participant Brochure
• Frequently Asked Questions
• Informational Flyer
• Key Personnel

  Protocol Chair:  Claudio Anasetti, MD (813-745-3243) anasetc@moffitt.usf.edu

  Protocol Officer:  Dennis Confer, MD (612-362-3425) dconfer@nmdp.org

  Protocol Coordinator: Cathy Gurgol (301-251-1161) cgurgol@emmes.com

  Medical Monitor: Chris Bredeson, MD (414-805-4626) bredeson@mcw.edu

The BMT CTN is committed to including widespread transplant community participation in these trials.  The application submission period for participation in this protocol is now closed; however your center may still want to complete the Affiliate Center Application, or you may complete the short form if currently participating as a non-core center in any other BMT CTN trial, and in the event that more centers are added, we will contact you.   Forms should be completed and faxed to the BMT CTN DCC at 301-251-1355.